Have a personal or library account? Click to login
Mesenchymal stem cell therapy in patients with Crohn’s disease — 5 year follow-up Cover

Mesenchymal stem cell therapy in patients with Crohn’s disease — 5 year follow-up

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 76 (2022): Issue 5-6 (December 2022)
By: Oleg V. Knyazev,  Anna V. Kagramanova and  Asfold I. Parfenov  
Open Access
|Dec 2022

Authors

Oleg V. Knyazev

Moscow Clinical Scientific Center named after A. S. Loginov, Moscow, Russia
Research Institute of Healthcare Organization and Medical Management, Moscow, Russia
National Medical Research Сenter of Coloproctology named after A. N. Ryzhykh, Moscow, Russia

Anna V. Kagramanova

Moscow Clinical Scientific Center named after A. S. Loginov, Moscow, Russia
Research Institute of Healthcare Organization and Medical Management, Moscow, Russia

Asfold I. Parfenov

kagramanova@me.com

Moscow Clinical Scientific Center named after A. S. Loginov, Moscow, Russia
DOI: https://doi.org/10.2478/prolas-2022-0095 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 618 - 622
Published on: Dec 10, 2022
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
Crohn’s disease,
inflammatory bowel disease,
infliximab,
mesenchymal stromal cells
Related subjects:
General interest,
Mathematics,
General mathematics

© 2022 Oleg V. Knyazev, Anna V. Kagramanova, Asfold I. Parfenov, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 76 (2022): Issue 5-6 (December 2022)Next article